At the news
? NEUTRALIMPACT 2/10 144 filed Oct 30, 2026 at 16:15 ET
Director Kathryn Guarini filed a Form 144 notice of intent to sell 400 shares of Regeneron common stock, valued at approximately $360,000 based on the filing price. The shares were acquired through option exercise and the sale is a routine, small disposition relative to the director's total holdings and the company's $83.7B market cap.
- Director Kathryn Guarini filed Form 144 to sell 400 shares of Regeneron common stock.
- Estimated value of the proposed sale is $360,000.
- Shares were acquired via exercise of stock options on October 30, 2026.
- The sale is a small fraction of the director's total holdings (101,630,713 shares outstanding).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access